Project Grant R43HG013628
Award Date
9/19/24
Completion Date
8/31/25
Dollars Obligated
$399K
Federal Agency
National Human Genome Research Institute
Awardee
Galatea Bio Inc. (XNAMVB2KWVM1)
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
Hialeah, FL 33010, USA
Similar Awards
This Project Grant award from the National Human Genome Research Institute (NHGRI), under the Human Genome Research program (CFDA 93.172), aims to develop new methods to predict disease risk among individuals with rare monogenic risk alleles. The $1,100,866 award will fund research at the Icahn School of Medicine at Mount Sinai to leverage deep learning techniques on Electronic Health Records, metabolomics, and proteomics data from sources like the UK Biobank and NIH All of Us program. The...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) aims to develop novel transfer learning algorithms to improve the accuracy of polygenic scores (PGS) for predicting phenotypes and disease risk in ancestry groups underrepresented in genomics research. The $478,037 award will fund three specific objectives: 1) developing and benchmarking penalized regression and Bayesian methods for PGS...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $716,587 to Boston Children's Hospital to advance equity in rare disease genomic research. The key objectives are to: Develop and implement a Diversity, Equity, and Inclusion toolkit within the Broad Institute's Rare Genomes Project to improve engagement and participation from historically underrepresented populations in rare disease genomic studies. This will involve...
This Project Grant award, valued at $491,366, was issued by the National Human Genome Research Institute (NHGRI) under the Human Genome Research federal grant program (CFDA 93.172). The award is focused on developing new algorithms to robustly map disease-associated genetic variants to critical target genes, particularly in underrepresented populations. Key objectives include: Improving the ability to identify disease-critical genes in non-European populations where data is limited. Developing...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) aims to develop novel statistical models for multi-trait analysis in large-scale biobank datasets linked to electronic health records. The $122,234 award, effective from September 20, 2024 to August 31, 2026, will support research at Columbia University's Health Sciences Division to enhance disease association mapping and risk prediction accuracy. Specifically, the project will: 1)...
This Project Grant award, with the ID R01HG013163, was provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research federal grant program (CFDA 93.172). The $1,604,308.15 award supports a multi-omics study of ancestry-enriched associations in Hispanic/Latino populations, which aims to leverage genomic and multi-omics data to map genomic segments and variants inherited from ancestral populations and assess their relationship to disease states. The key...
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) to the University of California, Davis is focused on understanding the role of gene-gene interactions (epistasis) in genetic prediction and portability across diverse ancestral populations. The $281,751 award, with a project period from September 1, 2024 to August 31, 2026, will enable the researchers to generate a large genome-wide methylation dataset from 500 admixed South African...
This Project Grant award from the National Human Genome Research Institute (NHGRI), under the federal Human Genome Research grant program (CFDA 93.172), is focused on enhancing the interpretability and applicability of polygenic scores through the integration of multi-omics data and family-based studies. The primary objectives are to: 1) develop machine learning approaches to integrate genetic, multi-omics, and environmental data to construct partitioned polygenic scores representing distinct...
This $993,446 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) will support the development of statistical and machine learning approaches to decode the regulatory activity underlying disease variants, link variants to genes in relevant cell types, and identify disease-critical co-operative programs of genes and genomic elements. The key objectives are to: 1) leverage single-cell multi-omics data to improve strategies for linking...
The National Human Genome Research Institute (NHGRI) awarded a $457,920 Project Grant (CFDA #93.172 - Human Genome Research) to The Broad Institute, Inc. to develop a deep reinforcement learning framework for haplotype assembly. Haplotype assembly is critical for understanding human population genetics and disease, as it reconstructs the combination of alleles on maternally and paternally inherited chromosome copies. The Broad Institute, a renowned biomedical and genomic research organization,...